Know Cancer

or
forgot password

    • cancer clinical trials in langhorne, PA

    • Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Lymphoma
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Esophageal Cancer, Gastric Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Mary Medical and Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Saint Mary Medical and Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Mary Medical and Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Saint Mary Medical and Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Patients With Advanced Non-Small Cell Lung Cancer
    St. Mary Medical Center- Oncology, Hematology PC
    Langhorne, Pennsylvania 19047
    Non-Small Cell Lung Carcinoma
    Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer
    Regional Hematology Oncology Associates Pc
    Langhorne, Pennsylvania 19047
    Prostatic Neoplasms
    Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
    1199.14.1065 Boehringer Ingelheim Investigational Site
    Langhorne, Pennsylvania
    Carcinoma, Non-Small-Cell Lung
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    St. Mary Medical Center Hem-Onc Group, PC
    Langhorne, Pennsylvania 19047
    Metastatic Pancreatic Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Saint Mary Medical and Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Lung Cancer
    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
    Saint Mary Medical and Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Breast Cancer
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Breast Cancer
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Saint Mary Medical and Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Saint Mary Medical and Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Head and Neck Cancer, Precancerous Condition
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    St. Mary Medical Center
    Langhorne, Pennsylvania 19047
    Breast Cancer
    PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
    St. Mary Medical Center
    Langhorne, Pennsylvania 19047
    Hormone Receptor Positive Malignant Neoplasm of Breast
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
    St Mary Medical Center
    Langhorne, Pennsylvania 19047
    Squamous Cell Non-small Cell Lung Cancer
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Non-squamous NSCLC
    St. Mary Medical Center
    Langhorne, Pennsylvania 19047
    Non-Squamous Cell Non-small Cell Lung Cancer
    Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer
    Saint Mary Regional Center
    Langhorne, Pennsylvania 19047
    Head and Neck Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Saint Mary Regional Center
    Langhorne, Pennsylvania 19047
    Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Anal Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Saint Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Breast Cancer
    Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
    Saint Mary Medical Center
    Langhorne, Pennsylvania 19047
    Kidney Cancer
    Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    Saint Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Prostate Cancer
    Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
    Saint Mary Regional Center
    Langhorne, Pennsylvania 19047
    Multiple Myeloma and Plasma Cell Neoplasm
    Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Saint Mary Regional Center
    Langhorne, Pennsylvania 19047
    Lymphoma
    Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer
    Saint Mary Regional Center
    Langhorne, Pennsylvania 19047
    Lung Cancer
    STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
    Regional Hematology Oncology Assoc
    Langhorne, Pennsylvania 19047
    Neoplasms, Diarrhea
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Pancreatic Cancer
    The Plenaxis® Experience Study
    Dr. Peter Sinaiko
    Langhorne, Pennsylvania 19047
    Prostate Cancer
    OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
    St. Mary Medical Center
    Langhorne, Pennsylvania 19047
    Pain, Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    St. Mary Regional Cancer Center
    Langhorne, Pennsylvania 19047
    Breast Cancer
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    St. Mary Medical Center--Research Center

    Trial Locations
    St. Mary Medical Center--Research Center
    Hematology-Oncology Group, PC
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
    St Mary Medical Center

    Trial Locations
    St Mary Medical Center
    Regional Hematology Oncology, PC
    Breast Neoplasms